Baz M - Search Results

1

Zika Virus Isolation, Purification, and Titration.

Baz M. Baz M. Methods Mol Biol. 2020;2142:9-22. doi: 10.1007/978-1-0716-0581-3_2. Methods Mol Biol. 2020. PMID: 32367355

2

In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin.

Baz M, Goyette N, Griffin BD, Kobinger GP, Boivin G. Baz M, et al. Antivir Ther. 2017;22(7):613-618. doi: 10.3851/IMP3180. Epub 2017 Jul 11. Antivir Ther. 2017. PMID: 28694390

3

Predominant role of IPS-1 over TRIF adaptor proteins in early innate immune response against Zika virus in mice.

Piret J, Carbonneau J, Rhéaume C, Baz M, Boivin G. Piret J, et al. Among authors: baz m. J Gen Virol. 2018 Feb;99(2):209-218. doi: 10.1099/jgv.0.000992. Epub 2018 Jan 3. J Gen Virol. 2018. PMID: 29297844

4

Antiviral Agents in Development for Zika Virus Infections.

Baz M, Boivin G. Baz M, et al. Pharmaceuticals (Basel). 2019 Jun 29;12(3):101. doi: 10.3390/ph12030101. Pharmaceuticals (Basel). 2019. PMID: 31261947 Free PMC article. Review.

5

Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors.

Stephen P, Baz M, Boivin G, Lin SX. Stephen P, et al. Among authors: baz m. J Am Chem Soc. 2016 Dec 21;138(50):16212-16215. doi: 10.1021/jacs.6b10399. Epub 2016 Dec 6. J Am Chem Soc. 2016. PMID: 27998085

6

Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus.

Baz M, M'hamdi Z, Carbonneau J, Lavigne S, Couture C, Abed Y, Boivin G. Baz M, et al. Among authors: m hamdi z. Sci Rep. 2019 Nov 12;9(1):16616. doi: 10.1038/s41598-019-51877-4. Sci Rep. 2019. PMID: 31719554 Free PMC article.

7

Replication and transmission of an influenza A(H3N2) virus harboring the polymerase acidic I38T substitution, in guinea pigs.

Mhamdi Z, Carbonneau J, Venable MC, Baz M, Abed Y, Boivin G. Mhamdi Z, et al. Among authors: baz m. J Gen Virol. 2021 Oct;102(10). doi: 10.1099/jgv.0.001659. J Gen Virol. 2021. PMID: 34661516

8

A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.

Abed Y, Baz M, Boivin G. Abed Y, et al. Among authors: baz m. J Infect Dis. 2009 Jan 15;199(2):180-3. doi: 10.1086/595736. J Infect Dis. 2009. PMID: 19046066

9

Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.

Baz M, Abed Y, Simon P, Hamelin ME, Boivin G. Baz M, et al. J Infect Dis. 2010 Mar;201(5):740-5. doi: 10.1086/650464. J Infect Dis. 2010. PMID: 20100088

10

Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.

Hamelin ME, Baz M, Abed Y, Couture C, Joubert P, Beaulieu E, Bellerose N, Plante M, Mallett C, Schumer G, Kobinger GP, Boivin G. Hamelin ME, et al. Among authors: baz m. PLoS Pathog. 2010 Jul 22;6(7):e1001015. doi: 10.1371/journal.ppat.1001015. PLoS Pathog. 2010. PMID: 20661429 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters